Alberto Bongiovanni

Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.

Cytokine gene polymorphisms and breast cancer susceptibility.

CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems.

Single bone metastasis from adenocarcinoma of the lacrimal gland: a case report.

111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance.

Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature.

Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview.

Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case report.

Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.

Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PET.

First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma.

Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report.

Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model.

Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR).

RANKL: A promising circulating marker for bone metastasis response.

Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with (177)Lu-D OTATATE.

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas.

Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with (177)Lu-D OTATATE.

The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts.

Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model.

Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma.

Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of (18)FDG-PET/CT.

Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway.

CORRECTION: Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model.

Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life.

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas.

Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors.

Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition.

Management and potentialities of primary cancer cultures in preclinical and translational studies.

Primary leiomyosarcoma of the bone: a case report and a review of the literature.

Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature.

Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.

Myxofibrosarcoma primary cultures: molecular and pharmacological profile.